Slide 1: opstt Y
opstt Y
Slide 2: Disclaimer
DISCLAIMER This presentation also contains estimates and other statistical data made by independent parties and by the Company relating to market size the concentration of our voting power as a result of our dual class structure; our status as a foreign private issuer; and other risk factors set and
Slide 3: Our vision is to transform the global beauty & wellness market
OUR VISION IS TO TRANSFORM THE GLOBAL BEAUTY & WELLNESS MARKET THROUGH ISRAELI TECHNOLOGY & ENTREPRENEURIAL THINKING FOR THE BENEFIT OF CONSUMERS ALL OVER THE WORLD. 3
Slide 4: Our technology platform supports a portfolio of powerhouse brands
OUR TECHNOLOGY PLATFORM SUPPORTS A PORTFOLIO OF POWERHOUSE BRANDS 4
Slide 5: $ODD Financial Highlights
$ODD FINANCIAL HIGHLIGHTS $647M $150M $169M Net revenue, Adjusted EBITDA1, Cash, cash equivalents, FY2024 FY2024 & investments4 +27% 23% $134M YoY net revenue Adjusted EBITDA2 Free cash flow3, growth, FY2024 margin, FY2024 FY2024 Note: 1. Adjusted EBITDA is a supplemental measure of our performance
Slide 6: A rare combination of scale + growth + profitability
A RARE COMBINATION OF SCALE + GROWTH + PROFITABILITY +27% +57% NET REVENUE GROWTH1 +46% $647M +101% $509M $325M $223M NET REVENUE $150M $107M ADJUSTED EBITDA2 $27M $39M FY21 FY22 FY23 FY24 Note: 1. Percentages reflect year-over-year growth rates for the same period of the prior year. 2. Adjusted EBI
Slide 7: Q4 results exceeded guidance
Q4 RESULTS EXCEEDED GUIDANCE Q4 2024 ACTUAL GUIDANCE NET REVENUE GROWTH 27% 22 to 24% GROSS MARGIN 72.7% 68.0% ADJUSTED EBITDA1 $15mn $12mn to $14mn ADJUSTED DILUTED EPS2 $0.20 $0.11 to 0.13 Note: 1. Adjusted EBITDA is a supplemental measure of our performance that is not required by, or presented i
Slide 8: Q1 and FY 2025 financial outlook
Q1 AND FY 2025 FINANCIAL OUTLOOK GUIDANCE 1Q 2025 FY2025 Current Current NET REVENUE GROWTH 22 to 24% / 20 to 21% / %/$ $258 to 262mn $776 to 785mn GROSS MARGIN 72.0% 70.0% ADJUSTED EBITDA1 $ $49 to 50mn $155 to 158mn ADJUSTED DILUTED EPS2 $0.61 to 0.63 $1.94 to 1.98 Note: 1. Adjusted EBITDA is a su
Slide 9: Q4 2024 highlights
Q4 2024 HIGHLIGHTS In millions Q4 2024 vs Q4 2023 Net Revenue $123.6 +27% Gross Margin 72.7% +330 bps 1 Adjusted EBITDA $15.2 -7% 2 Adjusted EBITDA margin 12.3% -453 bps 3 Adjusted Diluted EPS $0.20 +18% Note: 1. Adjusted EBITDA is a supplemental measure of our performance that is not required by, o
Slide 10: FY 2024 highlights
FY 2024 HIGHLIGHTS In millions FY 2024 vs FY 2023 Net Revenue $647.0 +27% Gross Margin 72.4% +196 bps 1 Adjusted EBITDA $150.4 +40% 2 Adjusted EBITDA margin 23.3% +215bps 3 Adjusted Diluted EPS $1.96 +50% Note: 1. Adjusted EBITDA is a supplemental measure of our performance that is not required by,
Slide 11: Appendix
APPENDIX 11
Slide 12: Reconciliations to adjusted metrics
RECONCILIATIONS TO ADJUSTED METRICS U.S. dollar in thousands (except per share data) 1 2 Note: 1. Adjusted EBITDA is a supplemental measure of our performance that is not required by, or presented in accordance with, GAAP. Adjusted EBITDA should not be considered as an alternative to net income or a
Slide 13: Reconciliation of net cash provided by operating activities to free cash flow
RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO FREE CASH FLOW U.S. dollar in thousands (except per share data) 1 Note: 1. Free Cash Flow defined as Net Cash from Operating Activities less purchase of Property, Plant and Equipment. 13